Liraglutide vs Upadacitinib
Liraglutide vs Upadacitinib: Overview
This comparison examines the pharmacological differences between Liraglutide and Upadacitinib.
Mechanism of Action
Liraglutide: GLP-1 receptor agonist enhancing insulin secretion.
Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.
Pharmacokinetics
Half-life: Liraglutide — 13 hours; Upadacitinib — 9-14 hours.
Chemical Properties
Molecular Formula: Upadacitinib — C17H19F3N6O.
Molecular Weight: Upadacitinib — 380.3700 g/mol.
Type: Liraglutide — Protein; Upadacitinib — Small molecule.